Laurion Capital Management’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Laurion Capital Management’s Portfolio OMGA Stock Details OMGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-24,155	Closed	-$135K	–	712
2023 Q2	$135K	Sell	24,155 -546,953	-96%	-$4.28M	﹤0.01%	503
2023 Q1	$3.44M	Buy	571,108 +138,408	+32%	+$964K	0.02%	256
2022 Q4	$2.47M	Hold	432,700	–	–	0.01%	303
2022 Q3	$2.35M	Hold	432,700	–	–	0.01%	318
2022 Q2	$1.64M	Buy	+432,700	New	+$1.61M	0.03%	245

Other funds holding OMGA

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Laurion Capital Management's OMGA Position: Q3 2023 in Review

Laurion Capital Management sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q3 2023, closing a stake of 24,155 shares — an estimated $135K sold.

Laurion Capital Management first reported a position in OMGA in Q2 2022 and held it in 5 quarters. The position peaked at $3.44M in Q1 2023. 58 funds tracked by Wall St. Rank hold OMGA as of Q3 2023.

Laurion Capital Management reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Laurion Capital Management sold 24,155 Omega Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $135K.
Laurion Capital Management first reported a position in Omega Therapeutics, Inc. Common Stock in Q2 2022 and held it in 5 quarters.
Laurion Capital Management's Omega Therapeutics, Inc. Common Stock position peaked at $3.44M in Q1 2023.
58 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Laurion Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.